Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;10(7):629-630.
doi: 10.1002/ueg2.12302. Epub 2022 Aug 31.

Burden of obesity in gastrointestinal and liver diseases

Affiliations
Editorial

Burden of obesity in gastrointestinal and liver diseases

Zeljko Krznaric. United European Gastroenterol J. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author has no conflict of interest to declare regarding this manuscript.

Comment on

References

    1. Bischoff SC, Barazzoni R, Busetto L, Campmans‐Kuijpers M, Cardinale V, Chermesh I, et al. European Guideline on Obesity care in patients with gastrointestinal and liver diseases – joint ESPEN/UEG guideline. United European Gastroenterol J. 2022; 1–58. 10.1002/ueg2.12280 - DOI - PMC - PubMed
    1. Singh S, Picardo S, Seow CH. Management of inflammatory bowel diseases in special populations: obese, old, or obstetric. Clin Gastroenterol Hepatol. 2020;18(6):1367–80. Epub 2019 Nov 8. PMID: 31712084; PMCID: PMC7183892. 10.1016/j.cgh.2019.11.009 - DOI - PMC - PubMed
    1. Bischoff SC, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, et al. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2020;39(3):632–53. Epub 2020 Jan 13. PMID: 32029281. 10.1016/j.clnu.2019.11.002 - DOI - PubMed
    1. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros‐Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321–35. Epub 2022 Feb 23. PMID: 35196654; PMCID: PMC9210010. 10.1159/000521241 - DOI - PMC - PubMed
    1. Kirchgesner J. Paving the way towards a weight‐loss intervention study in obese patients with inflammatory bowel disease. United European Gastroenterol J. 2020;8(10):1143–4. Epub 2020 Oct 12. PMID: 33045939; PMCID: PMC7724523. 10.1177/2050640620965113 - DOI - PMC - PubMed